Fig. 1From: Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementiaPatient loss due to missing data. The absolute sample size is given in the rectangles; the loss of sample size due to missing data of the respective measures is given in the diamonds. AD Alzheimer’s disease, CSF cerebrospinal fluid, MCI mild cognitive impairmentBack to article page